title: Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms.
abstract: We have recently identified protein phosphatase 1β (PP1β) as G protein-coupled receptor (GPCR) phosphatase for the sst2 somatostatin receptor using siRNA knockdown screening. By contrast, for the sst5 somatostatin receptor we identified protein phosphatase 1γ (PP1γ) as GPCR phosphatase using the same approach. We have also shown that sst2 and sst5 receptors differ substantially in the temporal dynamics of their dephosphorylation and trafficking patterns. Whereas dephosphorylation and recycling of the sst2 receptor requires extended time periods of ∼30 min, dephosphorylation and recycling of the sst5 receptor is completed in less than 10 min. Here, we examined which receptor domains determine the selection of phosphatases for receptor dephosphorylation. We found that generation of tail-swap mutants between sst2 and sst5 was required and sufficient to reverse the patterns of dephosphorylation and trafficking of these two receptors. In fact, siRNA knockdown confirmed that the sst5 receptor carrying the sst2 tail is predominantly dephosphorylated by PP1β, whereas the sst2 receptor carrying the sst5 tail is predominantly dephosphorylated by PP1γ. Thus, the GPCR phosphatase responsible for dephosphorylation of individual somatostatin receptor subtypes is primarily determined by their different carboxyl-terminal receptor domains. This phosphatase specificity has in turn profound consequences for the dephosphorylation dynamics and trafficking patterns of GPCRs.
authors.affiliation: Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Lehmann
authors.affiliation: Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Kliewer
authors.affiliation: Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
authors.forename: Jan Carlo
authors.initials: JC
authors.lastname: Märtens
authors.affiliation: Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
authors.forename: Falko
authors.initials: F
authors.lastname: Nagel
authors.affiliation: Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Schulz
mesh_terms: D019390:Arrestins; D002460:Cell Line; D006801:Humans; D007527:Isoenzymes; D010766:Phosphorylation; D054730:Protein Interaction Domains and Motifs / Q000502:physiology*; D054645:Protein Phosphatase 1 / Q000378:metabolism*; D021381:Protein Transport; D017481:Receptors, Somatostatin / Q000737:chemistry* / Q000378:metabolism*; D013379:Substrate Specificity; D000071557:beta-Arrestins
chemical_list: D019390:Arrestins; D007527:Isoenzymes; D017481:Receptors, Somatostatin; D000071557:beta-Arrestins; D054645:Protein Phosphatase 1